• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Norwegian Cruise Line Shares Climbed By Around 12%; Here Are 66 Biggest Movers From Yesterday

    10/13/22 6:06:21 AM ET
    $ADMP
    $AGFY
    $AHG
    $ALB
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Farming/Seeds/Milling
    Consumer Staples
    Get the next $ADMP alert in real time by email

    Gainers

    • Pintec Technology Holdings Limited (NASDAQ:PT) shares jumped 216.2% to close at $0.9058 on Wednesday.
    • Agrify Corporation (NASDAQ:AGFY) climbed 88% to close at $ 0.9540 on Wednesday after climbing over 32% on Tuesday.
    • FLJ Group Limited (NASDAQ:FLJ) jumped 86.3% to close at $2.85 on Wednesday.
    • 9F Inc. (NASDAQ:JFU) gained 83.4% to close at $0.3485.
    • FOXO Technologies Inc. (NASDAQ:FOXO) jumped 59.3% to close at $1.43 after the company announced its insurance distribution subsidiary, FOXO LIFE, recruited its first distribution partner, BGA Insurance, to begin product rollout in California.
    • Happiness Development Group Limited (NASDAQ:HAPP) climbed 59.1% to close at $3.85. Happiness Development Group shareholders approved a 1 for 20 reverse split of ordinary shares.
    • Hempacco Co., Inc. (NASDAQ:HPCO) shares gained 43.4% to close at $3.14 after the company reported a 486% year-on-year jump in first-half FY22 revenue to about $2.8 million.
    • mCloud Technologies Corp. (NASDAQ:MCLD) jumped 39.4% to close at $2.23.
    • Code Chain New Continent Limited (NYSE:CCNC) shares climbed 38.8% to close at $0.2290 on Wednesday after declining around 14% on Tuesday.
    • Vigil Neuroscience, Inc. (NASDAQ:VIGL) gained 37% to close at $13.92.
    • Applied DNA Sciences, Inc(NASDAQ:APDN) rose 36.5% to close at $2.73. Applied DNA Sciences recently received its largest single purchase order for LinearDNA™ valued above the mid-six-figures.
    • Aspen Group, Inc. (NASDAQ:ASPU) rose 35.3% to settle at $0.4424 after the company cancelled its equity distribution agreement.
    • Pineapple Energy Inc.. (NASDAQ:PEGY) jumped 34% to close at $6.70. The stock has been a momentum name for a few weeks now.
    • Meta Materials Inc. (NASDAQ:MMAT) gained 33% to close at $1.05.
    • Oriental Culture Holding LTD (NASDAQ:OCG) rose 31.6% to close at $0.89.
    • Compugen Ltd. (NASDAQ:CGEN) gained 29.2% to close at $0.8521.
    • Gatos Silver, Inc. (NYSE:GATO) gained 29.1% to close at $3.33. Gatos Silver reported a 59% year-over-year surge in Q3 silver production.
    • Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) gained 28.8% to close at $0.79.
    • Celularity Inc. (NASDAQ:CELU) gained 20.9% to close at $2.26.
    • LumiraDx Limited (NASDAQ:LMDX) jumped 20.9% to settle at $1.04.
    • Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) surged 18% to close at $0.1728 after jumping over 16% on Tuesday. Adamis Pharmaceuticals recently announced a review of strategic alternatives.
    • ObsEva SA (NASDAQ:OBSV) rose 16.9% to close at $0.1851 after dropping 3% on Tuesday.
    • El Pollo Loco Holdings, Inc. (NASDAQ:LOCO) climbed 15.7% to close at $10.53 after the company declared a special dividend of $1.50 per share and approved a 20 million share buyback program.
    • FingerMotion, Inc. (NASDAQ:FNGR) gained 13.2% to settle at $8.95.
    • Pacific Biosciences of California, Inc. (NASDAQ:PACB) surged 13.1% to close at $6.41.
    • KnowBe4, Inc. (NASDAQ:KNBE) rose 12.7% to close at $24.33 after the company announced it will be acquired by Vista Equity Partners for $4.6 billion.
    • RLX Technology Inc. (NYSE:RLX) rose 12% to close at $1.12. RLX recently reported a second-quarter FY22 sales decline of 12% year-on-year to $333.50 million.
    • Greenwave Technology Solutions, Inc. (NASDAQ:GWAV) rose 11.7% to close at $1.24.
    • Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) gained 11.6% to settle at $12.98 after UBS upgraded the stock from Neutral to Buy.
    • ShotSpotter, Inc. (NASDAQ:SSTI) surged 11.4% to close at $29.12.
    • Cango Inc. (NYSE:CANG) gained 10.6% to close at $2.50 after the company declared a special cash dividend of $0.50 per share.
    • AZZ Inc. (NYSE:AZZ) gained 9.5% to close at $33.31. AZZ, on Tuesday, reported worse-than-expected Q2 adjusted EPS results. The company said it will not issue full-year fiscal year 2023 guidance at this time.
    • Siyata Mobile Inc. (NASDAQ:SYTA) gained 8.4% to settle at $0.1399. Siyata Mobile recently agreed to sell 15.8 million shares and 1.59 million pre-funded warrants to certain institutional investors in a private placement.
    • Moderna, Inc. (NASDAQ:MRNA) climbed 8.3% to close at $130.72. Moderna said Merck & Co had exercised an option to jointly develop and potentially sell personalized mRNA-based cancer vaccine. The FDA also authorized Moderna and Pfizer-BioNTech bivalent Covid-19 vaccines for use as a booster dose in younger age groups.
    • China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) gained 7.2% to close at $0.7185. On October 11, China SXT Pharmaceuticals received the funds from Mr. Xiao who previously agreed to purchase 1,625,798 shares of the company, par value $0.08/share at a per share purchase price of $1.35.

     

     

    Losers

    • Owens & Minor, Inc. (NYSE:OMI) fell 35% to close at $15.10 after the company lowered its F22 adjusted EPS guidance. The company named Alexander J. Bruni as EVP and CFO.
    • FedNat Holding Company (NASDAQ:FNHC) shares dipped 33.9% to close at $0.2245 on Wednesday after jumping 108% on Tuesday.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) fell 30% to close at $0.0560 after the company cut FY22 sales guidance to below analyst estimates and announced a 1-for-50 reverse stock split.
    • Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) declined 29.6% to close at $10.02.
    • Kinnate Biopharma Inc. (NASDAQ:KNTE) shares fell 26.7% to close at $8.12. Kinnate Biopharma late Tuesday said, 'Initial site activation was slower than expected due to COVID-19. This has resulted in a limited number of efficacy evaluable patients to-date in the relevant population at the predicted efficacious dose.'
    • Uxin Limited (NASDAQ:UXIN) fell 26.5% to close at $0.4478 after the company announced a 1-for-10 reverse ADS split.
    • Nemaura Medical Inc. (NASDAQ:NMRD) dropped 25.2% to close at $2.29. Nemaura received provisional purchase order from Middle East licensee TPMENA for the company's SugarBEAT system.
    • Mercurity Fintech Holding Inc. (NASDAQ:MFH) fell 23% to close at $0.8083.
    • Oblong, Inc. (NASDAQ:OBLG) fell 22.4% to close at $0.1817.
    • Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) dropped 20.5% to close at $0.11.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) fell 20.5% to close at $1.34. The company said, for the quarter ended September 30, 2022, it expects to report total revenue of approximately $4.6 million.
    • Minerva Surgical, Inc. (NASDAQ:UTRS) dropped 20.4% to close at $0.5969.
    • HeartBeam, Inc. (NASDAQ:BEAT) fell 20% to close at $4.15.
    • Mawson Infrastructure Group, Inc. (NASDAQ:MIGI) dropped 15.1% to close at $0.47.
    • Cameco Corporation (NYSE:CCJ) fell 13.6% to close at $22.30 after the company announced a $650 million bought deal offering of common shares at a price of $21.95 per share.
    • Akso Health Group (NASDAQ:AHG) fell 14.3% to close at $0.69.
    • Rumble Inc. (NASDAQ:RUM) dipped 13.2% to close at $10.21.
    • Enviva Inc. (NYSE:EVA) dropped 13.1% to close at $51.23 after Blue Orca issued a bearish report on the stock.
    • Nutex Health Inc. (NASDAQ:NUTX) declined 12.1% to close at $0.5540. Nutex Health recently provided a corporate update.
    • Blend Labs, Inc. (NYSE:BLND) fell 12.1% to close at $2.25.
    • Nuwellis, Inc. (NASDAQ:NUWE) fell 11.9% to close at $0.37.
    • Koninklijke Philips N.V. (NYSE:PHG) shares fell 11.7% to close at $13.17. Philips said it expects third-quarter group sales to be approximately €4.3 billion with a comparable sales decline of approximately 5%. Due to the lower sales, Group Adjusted EBITA for the quarter is expected to be around €210 million or around 5% of sales.
    • Sunnova Energy International Inc. (NYSE:NOVA) dropped 11.6% to close at $18.24.
    • Bright Health Group, Inc. (NYSE:BHG) fell 11.1% to settle at $1.04.
    • Getty Images Holdings, Inc. (NYSE:GETY) dipped 10.8% to close at $6.03. Benchmark upgraded Getty Images to Buy from Hold with a $9 price target.
    • ZeroFox Holdings, Inc. (NASDAQ:ZFOX) fell 10.5% to close at $4.62.
    • VOXX International Corporation (NASDAQ:VOXX) shares fell 9.3% to close at $6.55 after the company reported weaker-than-expected earnings results for its second quarter on Tuesday.
    • CTI BioPharma Corp. (NASDAQ:CTIC) fell 9.1% to close at $4.62.
    • Doximity, Inc. (NYSE:DOCS) fell 8.4% to close at $26.87.
    • Albemarle Corporation (NYSE:ALB) dropped 7.9% to close at $251.45.
    • WeWork Inc. (NYSE:WE) dropped 6% to close at $2.35.
    Get the next $ADMP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADMP
    $AGFY
    $AHG
    $ALB

    CompanyDatePrice TargetRatingAnalyst
    El Pollo Loco Holdings Inc.
    $LOCO
    3/6/2026$11.00Neutral
    DA Davidson
    Pacific Biosciences of California Inc.
    $PACB
    3/6/2026$1.50Equal Weight → Underweight
    Barclays
    AZZ Inc.
    $AZZ
    3/2/2026$132.00Overweight → Equal Weight
    Wells Fargo
    Albemarle Corporation
    $ALB
    2/17/2026$190.00Neutral → Buy
    BofA Securities
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    2/13/2026$20.00Overweight → Neutral
    Analyst
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    2/11/2026$23.00Overweight → Equal Weight
    Barclays
    Doximity Inc.
    $DOCS
    2/9/2026$34.00Hold → Buy
    Canaccord Genuity
    Doximity Inc.
    $DOCS
    2/6/2026$40.00Underweight → Neutral
    Analyst
    More analyst ratings

    $ADMP
    $AGFY
    $AHG
    $ALB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Veradace Partners Lp bought $162,056 worth of SOUNDTHINKING (22,789 units at $7.11), increasing direct ownership by 1% to 2,039,905 units (SEC Form 4)

    4 - SOUNDTHINKING, INC. (0001351636) (Issuer)

    2/24/26 5:35:39 PM ET
    $SSTI
    Computer Software: Prepackaged Software
    Technology

    Large owner Veradace Partners Lp bought $817,832 worth of SOUNDTHINKING (114,628 units at $7.13), increasing direct ownership by 6% to 2,017,116 units (SEC Form 4)

    4 - SOUNDTHINKING, INC. (0001351636) (Issuer)

    2/20/26 7:05:30 PM ET
    $SSTI
    Computer Software: Prepackaged Software
    Technology

    Large owner Veradace Partners Lp bought $4,029,659 worth of SOUNDTHINKING (578,485 units at $6.97), increasing direct ownership by 46% to 1,902,488 units (SEC Form 4)

    4 - SOUNDTHINKING, INC. (0001351636) (Issuer)

    2/18/26 4:02:53 PM ET
    $SSTI
    Computer Software: Prepackaged Software
    Technology

    $ADMP
    $AGFY
    $AHG
    $ALB
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZIMHI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug ZIMHI (ORIG-1) with active ingredient NALOXONE HYDROCHLORIDE has changed to 'Approval' on 10/15/2021. Application Category: NDA, Application Number: 212854, Application Classification: Type 5 - New Formulation or New Manufacturer

    10/18/21 11:55:40 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SYMJEPI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug SYMJEPI (SUPPL-12) with active ingredient EPINEPHRINE has changed to 'Approval' on 06/29/2021. Application Category: NDA, Application Number: 207534, Application Classification: Labeling

    6/30/21 5:11:48 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

    11/30/20 5:12:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADMP
    $AGFY
    $AHG
    $ALB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DA Davidson initiated coverage on El Pollo Loco with a new price target

    DA Davidson initiated coverage of El Pollo Loco with a rating of Neutral and set a new price target of $11.00

    3/6/26 8:32:59 AM ET
    $LOCO
    Restaurants
    Consumer Discretionary

    Pacific Biosciences downgraded by Barclays with a new price target

    Barclays downgraded Pacific Biosciences from Equal Weight to Underweight and set a new price target of $1.50

    3/6/26 8:26:02 AM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    AZZ downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded AZZ from Overweight to Equal Weight and set a new price target of $132.00

    3/2/26 8:53:30 AM ET
    $AZZ
    Industrial Specialties
    Industrials

    $ADMP
    $AGFY
    $AHG
    $ALB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Blend Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

    Blend Labs, Inc. (NYSE:BLND), a leading origination platform for digital banking solutions, today announced its preliminary fourth quarter and full year 2025 financial results. Blend also announced that its Board of Directors authorized a share repurchase program providing for the repurchase of up to $50 million of its Class A common stock. "I am pleased to report that Blend finished fiscal year 2025 with a strong fourth quarter, coming in near the high end of our revenue guidance and beating the high end of our non-GAAP operating income guidance," said Nima Ghamsari, Co-founder and Head of Blend. "What excites me most going into 2026 is not just our growing roster of customers — it's wha

    3/10/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Philips connects patient monitoring and diagnostics to advance platform-based care intelligence at HIMSS26

    March 10, 2026 Amsterdam, the Netherlands, and Las Vegas, USA – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today highlighted how open, interoperable, AI-enabled platforms can help health systems connect continuous patient monitoring with diagnostic insights – bringing the patient story together across time and across specialties. By connecting clinical signals with diagnostic information, Philips enables care teams to move from fragmented data to a more continuous, actionable understanding of the patient. Health systems are under unprecedented pressure, with rapidly growing data volumes stretching clinical capacity and contributing to care delays. Delays ar

    3/10/26 11:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    The Race for Uranium Has Gone Global

    VANCOUVER, British Columbia, March 10, 2026 (GLOBE NEWSWIRE) -- USANewsgroup.com News Commentary — The United States currently imports roughly 95% of the uranium it consumes, leaving the world's largest nuclear fleet almost entirely dependent on foreign fuel[1]. In January 2026, the White House issued a Section 232 proclamation formally designating uranium a national security risk, opening the door to import restrictions, price floors, and direct federal support for domestic miners[2]. Eagle Nuclear Energy Corp. (NASDAQ:NUCL), Cameco (NYSE:CCJ) (TSX:CCO), Denison Mines (NYSE-A: DNN) (TSX:DML), Centrus Energy (NYSE:LEU), and NuScale Power (NYSE:SMR) are each advancing projects that strength

    3/10/26 9:15:00 AM ET
    $CCJ
    $LEU
    $NUCL
    Other Metals and Minerals
    Basic Materials
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    $ADMP
    $AGFY
    $AHG
    $ALB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by SVP, Sales Arthur Kirk

    4 - SOUNDTHINKING, INC. (0001351636) (Issuer)

    3/10/26 4:28:38 PM ET
    $SSTI
    Computer Software: Prepackaged Software
    Technology

    Officer Golzadeh Nasim covered exercise/tax liability with 2,481 shares, decreasing direct ownership by 3% to 86,122 units (SEC Form 4)

    4 - SOUNDTHINKING, INC. (0001351636) (Issuer)

    3/10/26 4:27:46 PM ET
    $SSTI
    Computer Software: Prepackaged Software
    Technology

    EVP GC, CDO & Sec'y Farkas Daniel S was granted 44,887 shares, increasing direct ownership by 12% to 424,037 units (SEC Form 4)

    4 - Norwegian Cruise Line Holdings Ltd. (0001513761) (Issuer)

    3/10/26 4:19:00 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    $ADMP
    $AGFY
    $AHG
    $ALB
    SEC Filings

    View All

    SoundThinking Inc. filed SEC Form 8-K: Leadership Update

    8-K - SOUNDTHINKING, INC. (0001351636) (Filer)

    3/10/26 4:30:44 PM ET
    $SSTI
    Computer Software: Prepackaged Software
    Technology

    Nuwellis Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Nuwellis, Inc. (0001506492) (Filer)

    3/10/26 4:02:58 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Blend Labs Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Blend Labs, Inc. (0001855747) (Filer)

    3/10/26 4:01:12 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    $ADMP
    $AGFY
    $AHG
    $ALB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    12/5/24 7:27:01 PM ET
    $ALB
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by Greenwave Technology Solutions Inc.

    SC 13G - Greenwave Technology Solutions, Inc. (0001589149) (Subject)

    12/5/24 10:00:25 AM ET
    $GWAV
    Metal Fabrications
    Industrials

    Amendment: SEC Form SC 13D/A filed by Agrify Corporation

    SC 13D/A - Agrify Corp (0001800637) (Subject)

    11/29/24 4:30:03 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    $ADMP
    $AGFY
    $AHG
    $ALB
    Leadership Updates

    Live Leadership Updates

    View All

    NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products

    Transaction expected to approximately triple NEXGEL's annual revenue to about $35 million and is expected to make the Company immediately profitable upon closing Licensing and acquiring a diversified suite of 6 established regenerative biomaterial products, most with existing insurance reimbursement, along with three new product 510(k) filings planned for 2026, 2027, and 2028 Experienced commercial team is expected to join NEXGEL, significantly expanding the Company's sales reach and operational capabilities LANGHORNE, Pa., March 10, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of healthcare, beauty, and over-the-counter (OTC) pr

    3/10/26 8:45:00 AM ET
    $CELU
    $NXGL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments

    PacBio Announces the Appointment of Chris Gibson to the Board of Directors

    MENLO PARK, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading provider of high-quality, long-read sequencing technologies, today announced the appointment of Christopher Gibson, Ph.D., to PacBio's Board of Directors. Dr. Gibson is the co-founder and Chairman of the Board of Directors of Recursion (NASDAQ:RXRX), a clinical-stage biotechnology company that has built one of the industry's most advanced AI-driven drug discovery platforms. Under his leadership, Recursion integrated large-scale biological data generation with machine learning to industrialize the discovery process, building a vertically integrated technology stack spanning automation, high-dimensional b

    3/5/26 8:30:00 AM ET
    $PACB
    $RXRX
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

    MINNEAPOLIS, March 05, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of Stuart L. Goldstein, MD, FASN as Director of Clinical Strategy. Dr. Goldstein is internationally recognized as a pioneer in pediatric nephrology and critical care medicine. He serves as Director of the Center for Acute Care Nephrology, holds the Clark D. West Endowed Chair in Pediatric Nephrology at Cincinnati Children's Hospital Medical Center and is Professor of Pediatrics at the University of Cincinnati College of Medicine. His work has helped define the modern understand

    3/5/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ADMP
    $AGFY
    $AHG
    $ALB
    Financials

    Live finance-specific insights

    View All

    Blend Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

    Blend Labs, Inc. (NYSE:BLND), a leading origination platform for digital banking solutions, today announced its preliminary fourth quarter and full year 2025 financial results. Blend also announced that its Board of Directors authorized a share repurchase program providing for the repurchase of up to $50 million of its Class A common stock. "I am pleased to report that Blend finished fiscal year 2025 with a strong fourth quarter, coming in near the high end of our revenue guidance and beating the high end of our non-GAAP operating income guidance," said Nima Ghamsari, Co-founder and Head of Blend. "What excites me most going into 2026 is not just our growing roster of customers — it's wha

    3/10/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

    MINNEAPOLIS, March 10, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Recent Highlights: Fourth quarter revenue of $2.4 million, a 4% increase compared to the prior-year quarter and 9% increase sequentially.208% increase in U.S. console sales in Q4 versus prior year quarter.Heart Failure revenue increased 48% and Pediatrics increased 16% year-over-year in Q4.Gross margin of 68.2% in Q4, compared to 58.4% in the prior-year quarter.Closed a $5.0 million private p

    3/10/26 8:15:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM

    FULL YEAR 2025 HIGHLIGHTS:Total revenue of $875.3 million for the year 2025 versus $479.9 million for the year 2024, an increase of 82.4%Net income attributable to Nutex Health of $70.8 million for 2025 versus net income of $52.1 million for 2024, an increase of $18.7 millionDiluted EPS of $10.48 for 2025 versus diluted EPS of $9.69 for 2024EBITDA of $168.6 million for 2025 versus $98.8 million for 2024, an increase of 70.6%Adjusted EBITDA of $259.6 million for 2025 versus $102.8 million for 2024, an increase of 152.6%Net cash from operating activities of $248.1 million for 2025HOUSTON, March 5, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), today ann

    3/5/26 6:33:00 PM ET
    $NUTX
    Real Estate